Nature of Update

Incorporation of a wholly owned subsidiary for entry into medical devices and consumables manufacturing business.

Key Operational or Strategic Points

  • Royal Sandur MedTech Private Limited was incorporated on 25 September 2026 as a wholly owned subsidiary
  • The subsidiary will carry on business of medical devices and consumables manufacturing including manufacturing, processing, assembling, marketing and distribution of medical devices, surgical products, diagnostic products and healthcare consumables
  • The company received incorporation approval from Ministry of Corporate Affairs, Government of India
  • Investment made through subscription of equity shares in cash
  • Total investment: 10,00,000 equity shares of ₹10 each aggregating to ₹1,00,00,000 (₹1 crore)
  • 100% shareholding and control maintained by The Sandur Manganese & Iron Ores Limited

Material Financial Impact

  • Capital commitment of ₹1 crore for equity subscription
  • No disclosed impact on revenue, margins, cash flows, debt levels, or dividend policy
  • Funding from internal sources (cash consideration)